143 related articles for article (PubMed ID: 11765147)
1. Preclinical efficacy of travoprost, a potent and selective FP prostaglandin receptor agonist.
Hellberg MR; Sallee VL; McLaughlin MA; Sharif NA; Desantis L; Dean TR; Zinke PW
J Ocul Pharmacol Ther; 2001 Oct; 17(5):421-32. PubMed ID: 11765147
[TBL] [Abstract][Full Text] [Related]
2. Ocular hypotensive FP prostaglandin (PG) analogs: PG receptor subtype binding affinities and selectivities, and agonist potencies at FP and other PG receptors in cultured cells.
Sharif NA; Kelly CR; Crider JY; Williams GW; Xu SX
J Ocul Pharmacol Ther; 2003 Dec; 19(6):501-15. PubMed ID: 14733708
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of the ocular hypotensive efficacy of travoprost, a potent and selective FP prostaglandin receptor agonist, and AL-6598, a DP prostaglandin receptor agonist.
Hellberg MR; McLaughlin MA; Sharif NA; DeSantis L; Dean TR; Kyba EP; Bishop JE; Klimko PG; Zinke PW; Selliah RD; Barnes G; DeFaller J; Kothe A; Landry T; Sullivan EK; Andrew R; Davis AA; Silver L; Bergamini MV; Robertson S; Weiner AL; Sallee VL
Surv Ophthalmol; 2002 Aug; 47 Suppl 1():S13-33. PubMed ID: 12204698
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin subtype-selective and non-selective IOP-lowering comparison in monkeys.
Gabelt BT; Hennes EA; Bendel MA; Constant CE; Okka M; Kaufman PL
J Ocul Pharmacol Ther; 2009 Feb; 25(1):1-8. PubMed ID: 19232013
[TBL] [Abstract][Full Text] [Related]
5. Human trabecular meshwork cell responses induced by bimatoprost, travoprost, unoprostone, and other FP prostaglandin receptor agonist analogues.
Sharif NA; Kelly CR; Crider JY
Invest Ophthalmol Vis Sci; 2003 Feb; 44(2):715-21. PubMed ID: 12556403
[TBL] [Abstract][Full Text] [Related]
6. Responses of intraocular pressure and the pupil of feline eyes to prostaglandin EP1 and FP receptor agonists.
Bhattacherjee P; Williams BS; Paterson CA
Invest Ophthalmol Vis Sci; 1999 Nov; 40(12):3047-53. PubMed ID: 10549672
[TBL] [Abstract][Full Text] [Related]
7. The effects of prostaglandin analogues on IOP in prostanoid FP-receptor-deficient mice.
Ota T; Aihara M; Narumiya S; Araie M
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4159-63. PubMed ID: 16249494
[TBL] [Abstract][Full Text] [Related]
8. Preclinical pharmacology of AL-12182, a new ocular hypotensive 11-oxa prostaglandin analog.
Sharif NA; McLaughlin MA; Kelly CR; Xu S; Crider JY; Williams GW; Parker JL
J Ocul Pharmacol Ther; 2006 Oct; 22(5):291-309. PubMed ID: 17076623
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin analogues and mouse intraocular pressure: effects of tafluprost, latanoprost, travoprost, and unoprostone, considering 24-hour variation.
Ota T; Murata H; Sugimoto E; Aihara M; Araie M
Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2006-11. PubMed ID: 15914616
[TBL] [Abstract][Full Text] [Related]
10. Agonist activity of bimatoprost, travoprost, latanoprost, unoprostone isopropyl ester and other prostaglandin analogs at the cloned human ciliary body FP prostaglandin receptor.
Sharif NA; Kelly CR; Crider JY
J Ocul Pharmacol Ther; 2002 Aug; 18(4):313-24. PubMed ID: 12222762
[TBL] [Abstract][Full Text] [Related]
11. Travoprost--a new prostaglandin analogue for the treatment of glaucoma.
Whitson JT
Expert Opin Pharmacother; 2002 Jul; 3(7):965-77. PubMed ID: 12083996
[TBL] [Abstract][Full Text] [Related]
12. Effect of PF-04217329 a prodrug of a selective prostaglandin EP(2) agonist on intraocular pressure in preclinical models of glaucoma.
Prasanna G; Carreiro S; Anderson S; Gukasyan H; Sartnurak S; Younis H; Gale D; Xiang C; Wells P; Dinh D; Almaden C; Fortner J; Toris C; Niesman M; Lafontaine J; Krauss A
Exp Eye Res; 2011 Sep; 93(3):256-64. PubMed ID: 21376717
[TBL] [Abstract][Full Text] [Related]
13. IOP-Lowering Effect of ONO-9054, A Novel Dual Agonist of Prostanoid EP3 and FP Receptors, in Monkeys.
Yamane S; Karakawa T; Nakayama S; Nagai K; Moriyuki K; Neki S; Suto F; Kambe T; Hirota Y; Kawabata K
Invest Ophthalmol Vis Sci; 2015 Apr; 56(4):2547-52. PubMed ID: 25788650
[TBL] [Abstract][Full Text] [Related]
14. Endothelin antagonism: effects of FP receptor agonists prostaglandin F2alpha and fluprostenol on trabecular meshwork contractility.
Thieme H; Schimmat C; Münzer G; Boxberger M; Fromm M; Pfeiffer N; Rosenthal R
Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):938-45. PubMed ID: 16505027
[TBL] [Abstract][Full Text] [Related]
15. Cabergoline: Pharmacology, ocular hypotensive studies in multiple species, and aqueous humor dynamic modulation in the Cynomolgus monkey eyes.
Sharif NA; McLaughlin MA; Kelly CR; Katoli P; Drace C; Husain S; Crosson C; Toris C; Zhan GL; Camras C
Exp Eye Res; 2009 Mar; 88(3):386-97. PubMed ID: 18992242
[TBL] [Abstract][Full Text] [Related]
16. Effects of travoprost on aqueous humor dynamics in monkeys.
Toris CB; Zhan GL; Camras CB; McLaughlin MA
J Glaucoma; 2005 Feb; 14(1):70-3. PubMed ID: 15650608
[TBL] [Abstract][Full Text] [Related]
17. A dual acting compound with latanoprost amide and nitric oxide releasing properties, shows ocular hypotensive effects in rabbits and dogs.
Impagnatiello F; Borghi V; Gale DC; Batugo M; Guzzetta M; Brambilla S; Carreiro ST; Chong WK; Prasanna G; Chiroli V; Ongini E; Krauss AH
Exp Eye Res; 2011 Sep; 93(3):243-9. PubMed ID: 21356209
[TBL] [Abstract][Full Text] [Related]
18. Real-time intracellular Ca2+ mobilization by travoprost acid, bimatoprost, unoprostone, and other analogs via endogenous mouse, rat, and cloned human FP prostaglandin receptors.
Kelly CR; Williams GW; Sharif NA
J Pharmacol Exp Ther; 2003 Jan; 304(1):238-45. PubMed ID: 12490597
[TBL] [Abstract][Full Text] [Related]
19. Intraocular pressure lowering efficacy and safety of travoprost 0.004% as a replacement therapy in patients with open angle glaucoma or ocular hypertension.
Ge J; Sun XH; Wang NL; Zhao JL; Wu LL; Chen XM; Wang ZX; Li B
Chin Med J (Engl); 2010 Jun; 123(11):1417-21. PubMed ID: 20819599
[TBL] [Abstract][Full Text] [Related]
20. Local effect of topical FP-receptor agonists on retinal vessels of the ipsilateral posterior retina in normal rabbit eyes.
Ohashi M; Mayama C; Ishi K; Araie M
Clin Exp Ophthalmol; 2008 Nov; 36(8):767-74. PubMed ID: 19128383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
